Yahoo Finance: WisPaper Announces Upgrade to Streamline Research Workflows and Accelerate Knowledge Production
WisPaper, an AI-powered academic research agent, today announced a major upgrade designed to streamline complex research workflows. The update aims to reduce time spent on procedural tasks and enable ...
Avectas is a cell engineering technology business focused on improving the cost, manufacturing and patient outcomes for the next generation of cellular therapies.
Our vision is to position the non-viral Solupore® cell engineering technology to be integrated into manufacturing processes, including complex gene editing, for multiple autologous and allogeneic therapies and commercialized through development and license agreements.
“The key difference between our platform and competing technology is the gentleness. Currently, cells that are being modified are typically from a patient who may be ill and the cells may be fragile.
Morningstar: Made Scientific and Streamline Bio Launch Exclusive Early Adopter Program to Advance AI-Driven Robotic Automation for Cell Therapy Manufacturing
Partnership designates Made Scientific as exclusive cell therapy CDMO partner for Streamline Bio's platform, accelerating development of autonomous manufacturing workflows in GMP cleanroom ...
Made Scientific and Streamline Bio Launch Exclusive Early Adopter Program to Advance AI-Driven Robotic Automation for Cell Therapy Manufacturing
CNET on MSN: Google upgrades Maps features with more Gemini and faster photo uploads
Google Upgrades Maps Features With More Gemini and Faster Photo Uploads ...